Clinical Study
Safety and Efficacy of 188-Rhenium-Labeled Antibody to Melanin in Patients with Metastatic Melanoma
Table 3
Radiation-absorbed doses of 188Re-6D2 compared to tositumomab, ibritumomab tiuxetan, and normal organ tolerance TD 5/5 (cGy).
| | Liver | Kidneys | Bone marrow | Urine bladder wall |
| Tositumomab 81 mCi | 246 | 588 | 195 | 192 | Ibritumomab tiuxetan 30 mCi | 533 | 11 | 144 | 100 |
188Re-6D2 40–60 mCi | 130 | 305 | 17 | 158 |
188Re-6D2 Estimated 100 mCi | 344 | 650 | 42 | 350 | Normal Organ Tolerance | 3000 | 2300 | 200 | 6500 |
|
|